DLA PharmaceuticalsTypically replies within 1 hour

DLA Pharmaceuticals is a dynamic and research-driven pharmaceutical company dedicated to advancing scientific discovery by providing high-quality, research-grade products.
Our mission is to support scientists, academic institutions, and biotech industries with reliable tools that enable breakthrough innovations in medicine, biotechnology, and life sciences.

Quick Links

Home
Products
About Us
Contact

Resources

Blog
Search Products
Categories

Contact Us

+91 9899965625
sales@dlapharmaceuticals.com info@dlapharmaceuticals.com
201, 2nd floor, Eldeco Center, Block A
Shivalik Colony, Malviya Nagar, South Delhi
New Delhi, 110017

Loading...

© 2025 DLA Pharmaceuticals. All rights reserved.

Terms and Conditions
Privacy Policy

DLA PharmaceuticalsTypically replies within 1 hour

CD19/CD20 Double Knockout Raji/Luciferase Cell Line | DLA Pharmaceuticals

Cell Lines & MediaSecondary Cell Lines

CD19/CD20 Double Knockout Raji/Luciferase Cell Line

CAT Number

ABC-RC055Y

Unit Size

1 vial

Updated

March 16, 2026

Product Description

Product Category: Transfected Stable Cell Lines Product Type: Reporter Stable Cell Lines Recommended Medium & Supplement: RPMI 1640+ 10% FBS

Secondary Cell Lines

Secondary Cell Lines

Interested in this product?

Contact our team for pricing, availability, and technical support.

Browse More Products